Jump to main content
博士論文

Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair

Persistent ID (NDL)
info:ndljp/pid/13804043
Material type
博士論文
Author
位田, 奈緒子ほか
Publisher
-
Publication date
2024-09-30
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
福井大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

2024

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
位田, 奈緒子
Ida, Naoko
Publication Date
2024-09-30
Publication Date (W3CDTF)
2024-09-30
Alternative Title
イノツズマブオゾガマイシンとPARP阻害薬のオラパリブ、タラゾパリブの併用は急性リンパ性白血病に対しDNA損傷修復の阻害を通して相乗的な抗腫瘍効果を発揮する
Degree grantor/type
福井大学
Date Granted
2024-09-30
Date Granted (W3CDTF)
2024-09-30